Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models
Journal article
Rodriguez-Berriguete G. et al, (2023), Clinical Cancer Research
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.
Journal article
Emmenegger M. et al, (2023), iScience
A genome-wide CRISPR screen identifies CALCOCO2 as a regulator of beta cell function influencing type 2 diabetes risk.
Journal article
Rottner AK. et al, (2022), Nat Genet
Minimalised Three-Dimensional Human Midbrain In Vitro Model for Neurotoxicity Evaluation of DYRK1 Inhibitors
Preprint
Wan X. et al, (2022)
Small-molecule Polθ inhibitors provide safe and effective tumor radiosensitization in preclinical models
Preprint
Rodriguez-Berriguete G. et al, (2022)
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.
Journal article
Wei J. et al, (2022), Nat Commun, 13
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.
Journal article
Wei J. et al, (2022), Nat Med, 28, 1072 - 1082
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676
Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.
Journal article
Johanssen T. et al, (2022), Front Oncol, 12
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Preprint
Wei J. et al, (2021)
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region
Journal article
Emmenegger M. et al, (2020)